Evidence map›Paper›PMID 39895703›Full record

ArticleACS omega2025

Scalable and Practical Approach of Phenol Formation from Hydroxylation of Arylboronic Acids under Metal-, Photocatalyst-, and Light-Free Conditions.

Shuqing Cai, Noreen Rehmat, Zafar Mahmood, Qian Chen, Yanping Huo, Shaomin Ji

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuqing CaiSchool of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, P. R. China.
Noreen RehmatSchool of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, P. R. China.
Zafar MahmoodSchool of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, P. R. China.ORCID https://orcid.org/0000-0001-6500-5804
Qian ChenSchool of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, P. R. China.ORCID https://orcid.org/0000-0002-0818-6028
Yanping HuoSchool of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, P. R. China.ORCID https://orcid.org/0000-0003-4124-6026
Shaomin JiSchool of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, P. R. China.ORCID https://orcid.org/0000-0002-3304-2114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenols are of particular importance owing to their widespread application in various fields, including life sciences and synthetic chemistry. However, the typical synthetic strategies of phenol either rely on metal- or photo-catalysts or involve stringent conditions such as high temperature, strong oxidants, and acidic or basic environments. Herein, we present a remarkably simple, ecofriendly, and photocatalyst-free synthesis of phenols. In contrast to conventional methods, which relies on expensive catalysts or hazardous reagents, the current diacetoxyiodobenzene-mediated hydroxylation of arylboronic acid protocol offers significant improvement in terms of costs, operational simplicity, toxicity, and sustainability. The reaction does not require high temperature or light activation and shows good functional group compatibility and conversion efficiency (55-96%). Moreover, these mild reaction conditions are also useful for gram-scale synthesis without compromising the reaction yield.

Identifiers

PMID39895703
PMCPMC11780564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.